Abstract
INTRODUCTION
Despite its gradually decreasing incidence, gastric cancer remains the second leading cause of cancer death in the world [1] . Surgical resection and regional lymphadenectomy are the only curative options for patients with localized gastric tumors [2] [3] [4] . As early diagnosis and improved treatment have led to longerterm survival, patients are now more aware of the morbidities associated with gastrectomy, which is called postgastrectomy syndrome. Indeed, the gastrectomized patients may experience various nutritional and functional problems that interfere with their quality of life (QOL) [5] [6] [7] . Loss of body weight is a common complaint after gastrectomy, and is thought as one of few objective indices to measure the wellbeing of postgastrectomy patients. Some reports suggest that the type of gastrectomy is a certain predictor of postoperative weight loss [6, 8, 9] , however, other predictive factors for postoperative weight loss has yet not been determined. Though the low body mass index (BMI) as well as body weight loss is often identified after gastrectomy and may affects the QOL after gastrectomy [10] , their detail implication on the QOL has not been clarified.
The aim of the present study was to determine the predictive factors for postoperative weight loss and to investigate the impact of body weight loss and low BMI on the QOL in patients after gastrectomy using the Postgastrectomy Syndrome Assessment Scale (PGSAS)-45, which was established specifically to assess symptoms, living status and QOL among patients after gastrectomy [11] .
MATERIALS AND METHODS
The PGSAS study, a surveillance study involving 52 institutions, was conducted by the Japanese Postgastrectomy Syndrome Working Party (JPGSWP) and approved by the institutional review boards of all participating institutions. After completion of the informed consent process, patients were enrolled in this study if they met the following eligibility criteria: 20-75 years of age, histologically proven Stage Ⅰ gastric cancer based on the 13 th edition of the Japanese classification of gastric carcinoma [12] , curative resection at least 1 year after surgery, no signs of recurrence at the point of assessment, and no other active malignancy.
The PGSAS-45 questionnaire consists of 45 questions, with 8 items from the Short Form-8 (SF-8) [13] , 15 items from the Gastrointestinal Symptom Rating Scale [14] , and 22 clinically important items determined by the JPGSWP. Patients were given the questionnaire together with a stamped and addressed envelope in the outpatient clinic and were asked to complete questionnaire and return it by post to the data center. Of the 2922 patients to whom questionnaires were given during July 2009 to December 2010, 2520 (86%) responded and 2368 (81%) were confirmed to be eligible for the original study. Of these, the data from 1777 patients who underwent total gastrectomy with Roux-en-Y (TGRY) and distal gastrectomy with Billroth-I (DGBI) or Roux-en-Y (DGRY) were analyzed in this study.
Statistical analysis
The degree of body weight loss was compared among the three relevant preoperative BMI groups (BMI, < 18.5, 18.5-25 and > 25 kg/m 2 ) by multiple comparisons. Multiple regression analysis was performed to determine the factors affecting body weight loss after surgery, and to study the impact of the change in body weight and postoperative BMI on QOL. A P value of < 0.05 was considered to indicate statistical significance. 
RESULTS

Patient characteristics
A CONSORT flowchart of the PGSAS study is shown in Figure 1 . A total of 1777 patients (1188 men; 66.9%) who underwent conventional gastrectomy were enrolled in this study. The mean age of patients was 62.1 ± 9.2 years. The numbers of patients undergoing each operative procedure were as follows: TGRY, 393; DGRY, 475; and DGBI, 909. The mean time interval between surgery and retrieval of the questionnaires was 37.0 ± 26.8 mo, and the mean body weight loss among postgastrectomy patients was 9.5% ± 8.0% at that time (Table 1) .
QOL measures in the PGSAS-45
The PGSAS-45 is an integrated questionnaire for assessing the symptoms, the living status and the QOL in patients after gastrectomy, as described previously [11] . The structure of the PGSAS-45 is shown in Table 2 . QOL scores in the PGSAS-45 were obtained for two subdomains: dissatisfaction and the SF-8 items. The dissatisfaction subdomain consists of four outcome measures based on symptoms (item 43), meals (item 44), working (item 45), and daily life subscale (mean of the item 43-45). The SF-8 consists of eight items and generates two summary measures, the physical component summary and the mental component summary. The mean values of main outcome measures are shown in Table 3 .
Factors affecting postoperative weight loss
To clarify the predictive factors affecting change in body weight after surgery, multiple regression analysis was performed. In order of significance, higher preoperative BMI, type of gastrectomy (TGRY) and female sex were the independent predictors for postoperative weight loss (Table 4) .
Relationship between preoperative BMI and change in body weight
Considering that preoperative BMI was the most (Figure 2 ). There was a significant difference between each group (P < 0.0001) with a certain effect size in terms of Cohen's d. The patients with higher BMI (> 25 kg/m 2 ) exhibited the greatest weight loss (12.3%) among the groups, while the degree of weight loss in patients with lower BMI < (18.5) was spare (2%).
Impact of change in body weight and postoperative BMI on QOL
Finally, we performed multiple regression analysis to compare the influence on postoperative QOL between body weight loss and low postoperative BMI (Tables 5  and 6 ). The low postoperative BMI significantly affected on all QOL outcome measures with small but clinically meaningful effect size in terms of standardized partial regression coefficient (β), while the body weight loss only affected on some of QOL outcome measures with smaller effect size in β (approximately of half value compared to that of postoperative BMI). In addition, coefficient of determination R 2 , which indicates the aggregated impact of body weight loss and low postoperative BMI on the QOL, were relatively small for each QOL outcome measures.
DISCUSSION
This study identified the causal factors affecting body weight loss after gastrectomy and investigated the impact of body weight loss on the postoperative QOL using the PGSAS-45 questionnaire, which was recently developed to assess the QOL following gastrectomy. Our results identified higher preoperative BMI as the most influential factor affecting postoperative weight loss, followed by the type of gastrectomy performed (TGRY) and female sex, in order of significance. Moreover, the patients with higher BMI (> 25 kg/m 2 ) preoperatively exhibited the largest postoperative weight loss among three relevant preoperative BMI groups. The patients with low postoperative BMI experienced worse QOL than those with greater body weight loss, though the aggregated impact of low BMI and excess body weight loss on the QOL postoperatively was relatively smaller than generally considered.
Loss of body weight after gastrectomy is thought to be caused by multiple factors, including decreased serum ghrelin [15] , reduced food intake due to various abdominal symptoms, and disorder of digestive and absorptive function due to pancreatic exocrine insufficiency or postcibal pancreaticobilliary asynchrony. The degree of weight loss was also affected by the type of gastrectomy employed [15] [16] [17] [18] [19] . Additionally, body weight loss is also related to tumor progression or chemotherapy after surgery. In this study, we focused on Stage Ⅰ patients in order to exclude the influence of other factors that may influence the postoperative body weight, and to isolate the effect of the surgical procedures. The findings of present study that patients undergoing TGRY had a greater body weight loss compared to those undergoing DGBI or DGRY were compatible with the previous reports [19, 20] . However, the influence of the other surgical procedures such as laparoscopic approach or preservation of celiac branch of vagus, which maintains the postprandial motility of the duodenum and jejunum [21] and attenuates a dumping syndrome [22] , were insignificant as for effect size, β.
Recent analyzes of specific disease processes, Table 4 Factors influencing body weight loss after gastrec tomy (multiple regression analysis)
including sarcopenia and metabolic diseases, have identified the importance of evaluating not only BMI but also body component composition, such as body fat and skeletal muscle [23] [24] [25] [26] . Siervo et al [27] also reported that body composition varies with BMI, age and sex. Although a significant reduction in body fat has been reported after gastrectomy, several studies indicated that the reduction in skeletal muscle mass was smaller than reductions in the volume of body fat [28] [29] [30] [31] . These previous findings may, in part, explain the smaller body weight loss in patients with low BMI (< 18.5), in which, the proportion of the skeletal muscle supposed to be larger than those of the other relevant preoperative BMI groups.
Body weight loss is considered to be one of the objective index which resulting in worse QOL after gastrectomy [5, 8, 32, 33] , and also loss of body weight is associated with intolerance to adjuvant chemotherapy [34] . However, in clinical setting, excess body weight loss is not always accompanied with worse QOL, therefore, precise features of the impact of body weight loss on the postoperative QOL should be investigated. For this purpose, we studied the impact of body weight loss as well as postoperative BMI on the postgastrectomy QOL using the PGSAS-45 questionnaire, which is the first questionnaire developed to specifically measure QOL in gastrectomized patients [11, [35] [36] [37] [38] , by multiple regression analysis. The results of our study demonstrated that the preoperative BMI rather than the degree of body weight loss was the most influential predictor of worse QOL after gastrectomy. The low postoperative BMI significantly affected on all QOL outcome measures, though the body weight loss only affected few QOL outcome measures with smaller effect size in terms of β. The aggregated impact of low BMI and body weight loss was unexpectedly small for each QOL outcome measures in terms of R 2 . There may be other factors influencing worse QOL postgastrectomy, and future work should focus on investigation of other possible factors.
Despite above mentioned results, both to maintain postoperative body weight and to avoid low BMI seem yet important for better QOL after gastrectomy, therefore, enhanced perioperative nutritional management should be required particularly in patients with low preoperative BMI.
Several limitations of our study should be acknowledged. This study was not a prospective study and the investigation was performed at a single point in time postoperatively. We focused on long-term QOL, more than 1 year after gastrectomy based on previous findings that most QOL measures are stable at > 1 year postoperatively [39] . However, such QOL measurements at a single point in time may be insufficient to reflect the true impact of body weight loss. Further prospective and chronological studies assessing QOL over short-and longer-term periods after gastrectomy are required.
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COMMENTS
Background
Body weight loss, a common complaint after gastrectomy, is likely associated with various factors such as tumor progression and chemotherapy. While several reports indicated that the type of gastrectomy may be a determinant of postoperative weight loss, other risk factors have yet to be determined. In the present study, they focused only on patients with Stage I gastric cancer, so as to evaluate the impact of the surgical procedure without the confounding effect of other factors.
Research frontiers
Previous reports indicated that the type of gastrectomy is a certain postoperative weight loss, suggesting that total gastrectomy resulted in greater weight loss. Additionally, patients with excess weight loss after gastrectomy were shown to have lower performance status and difficulty in continuing chemotherapy. However, few reports have analyzed the relationship between postgastrectomy body weight loss and quality of life (QOL).
Innovations and breakthroughs
The authors aimed to determine the predictive factors and clarify the qualityof-life impact of postgastrectomy body weight loss and low body mass index. For this purpose, the authors used the postgastrectomy syndrome assessment scale-45, which was established specifically to evaluate QOL following Table 6 Regression analysis of effect size COMMENTS gastrectomy. Interestingly, the authors found that postoperative body mass index, rather than the degree of weight loss, was a predictor of worse QOL after gastrectomy, but the effect was relatively mild.
Applications
To minimize the negative effects on QOL after gastrectomy, it is better to maintain the postoperative body weight and avoid low body mass index. Postgastrectomy syndrome is a group of disorders and complications following gastrectomy. It includes early/late dumping syndrome, reflux gastritis, diarrhea, anemia, malabsorption, reflux gastritis, and weight loss.
